Jiangsu Hengrui Medicine Co Ltd (600276) — Tangible Net Worth Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has a Tangible Net Worth Ratio of 89.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥6.27 Billion) from net assets (CN¥60.03 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 600276 net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Hengrui Medicine Co Ltd Tangible Net Worth Ratio (1997–2024)
This chart shows how Jiangsu Hengrui Medicine Co Ltd's Tangible Net Worth Ratio has changed across 28 annual periods from 1997 to 2024. As of September 2025, the ratio stands at 89.5%, reflecting net assets of CN¥60.03 Billion with intangible assets of CN¥6.27 Billion CNY. For live market cap and overall valuation, see 600276 company net worth.
Annual Tangible Net Worth Ratio for Jiangsu Hengrui Medicine Co Ltd (1997–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Hengrui Medicine Co Ltd from 1997 to 2024, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Jiangsu Hengrui Medicine Co Ltd (600276) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.1% | CN¥46.09 Billion | CN¥5.03 Billion | CN¥50.14 Billion | ▼ -2.7 pp |
| 2023 | 91.8% | CN¥41.03 Billion | CN¥3.38 Billion | CN¥43.78 Billion | ▼ -2.5 pp |
| 2022 | 94.3% | CN¥38.41 Billion | CN¥2.20 Billion | CN¥42.36 Billion | ▼ -3.8 pp |
| 2021 | 98.0% | CN¥35.57 Billion | CN¥702.44 Million | CN¥39.27 Billion | ▼ -0.9 pp |
| 2020 | 98.9% | CN¥30.79 Billion | CN¥341.25 Million | CN¥34.73 Billion | ▲ +0.3 pp |
| 2019 | 98.6% | CN¥24.94 Billion | CN¥349.76 Million | CN¥27.56 Billion | ▼ 0.0 pp |
| 2018 | 98.6% | CN¥19.80 Billion | CN¥272.68 Million | CN¥22.36 Billion | ▲ +0.4 pp |
| 2017 | 98.2% | CN¥15.94 Billion | CN¥279.26 Million | CN¥18.04 Billion | ▲ +0.5 pp |
| 2016 | 97.8% | CN¥12.87 Billion | CN¥284.72 Million | CN¥14.33 Billion | ▼ -0.3 pp |
| 2015 | 98.1% | CN¥10.36 Billion | CN¥195.85 Million | CN¥11.50 Billion | ▲ +0.5 pp |
| 2014 | 97.6% | CN¥8.29 Billion | CN¥199.88 Million | CN¥9.09 Billion | ▲ +0.6 pp |
| 2013 | 97.0% | CN¥6.66 Billion | CN¥202.67 Million | CN¥7.22 Billion | ▼ -1.8 pp |
| 2012 | 98.8% | CN¥5.44 Billion | CN¥66.90 Million | CN¥5.89 Billion | ▼ -0.1 pp |
| 2011 | 98.8% | CN¥4.38 Billion | CN¥51.34 Million | CN¥4.82 Billion | ▲ +0.3 pp |
| 2010 | 98.5% | CN¥3.47 Billion | CN¥52.34 Million | CN¥3.90 Billion | ▲ +0.4 pp |
| 2009 | 98.1% | CN¥2.67 Billion | CN¥50.28 Million | CN¥3.00 Billion | ▼ -0.4 pp |
| 2008 | 98.6% | CN¥2.02 Billion | CN¥29.23 Million | CN¥2.25 Billion | ▲ +0.4 pp |
| 2007 | 98.2% | CN¥1.63 Billion | CN¥29.91 Million | CN¥2.01 Billion | ▲ +0.4 pp |
| 2006 | 97.7% | CN¥1.26 Billion | CN¥28.67 Million | CN¥1.46 Billion | ▼ -2.3 pp |
| 2005 | 100.0% | CN¥1.11 Billion | CN¥0.00 | CN¥1.29 Billion | ▲ +0.1 pp |
| 2004 | 99.9% | CN¥998.05 Million | CN¥656.52K | CN¥1.26 Billion | ▲ +1.4 pp |
| 2003 | 98.5% | CN¥903.35 Million | CN¥13.56 Million | CN¥1.45 Billion | ▲ +0.3 pp |
| 2002 | 98.2% | CN¥809.97 Million | CN¥14.36 Million | CN¥1.20 Billion | ▼ -1.5 pp |
| 2001 | 99.7% | CN¥757.99 Million | CN¥2.16 Million | CN¥1.12 Billion | ▼ -0.3 pp |
| 2000 | 100.0% | CN¥672.57 Million | CN¥0.00 | CN¥986.27 Million | ▲ +0.0 pp |
| 1999 | 100.0% | CN¥162.54 Million | CN¥0.00 | CN¥463.71 Million | ▲ +0.0 pp |
| 1998 | 100.0% | CN¥141.53 Million | CN¥0.00 | CN¥365.52 Million | ▲ +3.8 pp |
| 1997 | 96.2% | CN¥95.54 Million | CN¥3.62 Million | CN¥288.92 Million | — |